Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Braces that widen your jaw: do they change how you talk?

NCT ID NCT06981507

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how MARPE, a device that widens the upper jaw using small screws, affects speech in 30 teens and young adults aged 15 to 18. Researchers will analyze voice recordings before and after treatment to see if speech patterns change. The goal is to understand whether this common orthodontic procedure has any temporary or lasting effects on talking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MARPE (Miniscrew-Assisted Rapid Palatal Expansion) device
What this could lead to
If successful, this study could help orthodontists understand whether MARPE causes temporary or lasting speech changes, leading to better patient counseling.
What could go wrong
This is a small, early-stage observational study with only 30 participants. It does not test a treatment, so it cannot prove any benefit or harm beyond speech changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Aug 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with Class I malocclusion * Presence of maxillary transverse deficiency * Young adult patients aged 15 to 18 years * No history of systemic disease, cleft lip/palate, or speech disorders * No history of previous orthodontic treatment Exclusion Criteria: * Patients with any systemic disease * Patients who smoke * Patients with poor oral hygiene * Patients with cooperation difficulties * Patients with mental retardation or cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Evaluation of speech characteristics following marpe treatment in patients with maxillary transverse deficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Speech

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Necmettin Erbakan University, Faculty of Dentistry

    Konya, Meram, 42080, Turkey (Türkiye)